As of close of business last night, Cogent Biosciences Inc’s stock clocked out at $6.71, down -2.75% from its previous closing price of $6.90. In other words, the price has decreased by -$0.19 from its previous closing price. On the day, 958418 shares were traded.
Ratios:
To gain a deeper understanding of COGT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.09 and its Current Ratio is at 7.09. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on February 26, 2024, Downgraded its rating to Neutral and sets its target price to $8 from $14 previously.
On February 08, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $11.
Wedbush Downgraded its Outperform to Neutral on December 11, 2023, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 09 ’23 when Fairmount Funds Management LLC bought 800,000 shares for $12.00 per share. The transaction valued at 9,600,000 led to the insider holds 3,272,124 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COGT now has a Market Capitalization of 641.57M and an Enterprise Value of 454.74M.
Stock Price History:
Over the past 52 weeks, COGT has reached a high of $13.50, while it has fallen to a 52-week low of $3.67. The 50-Day Moving Average of the stock is 6.58, while the 200-Day Moving Average is calculated to be 8.68.
Shares Statistics:
It appears that COGT traded 2.24M shares on average per day over the past three months and 1.4M shares per day over the past ten days. A total of 103.91M shares are outstanding, with a floating share count of 87.22M. Insiders hold about 16.06% of the company’s shares, while institutions hold 75.78% stake in the company. Shares short for COGT as of Mar 15, 2024 were 9.63M with a Short Ratio of 4.31, compared to 6.24M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.27% and a Short% of Float of 9.52%.
Earnings Estimates
As of right now, 9 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.51 for the current quarter, with a high estimate of -$0.4 and a low estimate of -$0.59, while EPS last year was -$0.54. The consensus estimate for the next quarter is -$0.49, with high estimates of -$0.33 and low estimates of -$0.59.
Analysts are recommending an EPS of between -$1.41 and -$2.42 for the fiscal current year, implying an average EPS of -$2. EPS for the following year is -$1.99, with 9 analysts recommending between -$1.39 and -$2.7.
